Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP564860.RADbq8eDf7tHc1nccd6MIRtLpXxdVnOc1vl4-QbI44ZSA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP564860.RADbq8eDf7tHc1nccd6MIRtLpXxdVnOc1vl4-QbI44ZSA130_assertion type Assertion NP564860.RADbq8eDf7tHc1nccd6MIRtLpXxdVnOc1vl4-QbI44ZSA130_head.
- NP564860.RADbq8eDf7tHc1nccd6MIRtLpXxdVnOc1vl4-QbI44ZSA130_assertion description "[We undertook the current study with untreated breast cancer to (1) role the variations in the plasma levels of cfDNA and the size distribution in early stage, (2) determine the frequency in plasma of methylation of three candidate genes, RASSF1A, MAL, and SFRP1, and (3) to determine whether detection of cfDNA variations and methylation changes in plasma might have specific clinical utility.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP564860.RADbq8eDf7tHc1nccd6MIRtLpXxdVnOc1vl4-QbI44ZSA130_provenance.
- NP564860.RADbq8eDf7tHc1nccd6MIRtLpXxdVnOc1vl4-QbI44ZSA130_assertion evidence source_evidence_literature NP564860.RADbq8eDf7tHc1nccd6MIRtLpXxdVnOc1vl4-QbI44ZSA130_provenance.
- NP564860.RADbq8eDf7tHc1nccd6MIRtLpXxdVnOc1vl4-QbI44ZSA130_assertion SIO_000772 23011155 NP564860.RADbq8eDf7tHc1nccd6MIRtLpXxdVnOc1vl4-QbI44ZSA130_provenance.
- NP564860.RADbq8eDf7tHc1nccd6MIRtLpXxdVnOc1vl4-QbI44ZSA130_assertion wasDerivedFrom befree-20140225 NP564860.RADbq8eDf7tHc1nccd6MIRtLpXxdVnOc1vl4-QbI44ZSA130_provenance.
- NP564860.RADbq8eDf7tHc1nccd6MIRtLpXxdVnOc1vl4-QbI44ZSA130_assertion wasGeneratedBy ECO_0000203 NP564860.RADbq8eDf7tHc1nccd6MIRtLpXxdVnOc1vl4-QbI44ZSA130_provenance.